FDA investigates anti-spasm toxin in cerebal palsy child deaths
The US’s Food and Drug Administration said yesterday that it has opened a safety review on reported side effects of Botulinum Toxin for the treatment of a number of non-cosmetic conditions. Under review are Allergan brands Botox, Botox Cosmetic, and … Continue reading